Please take a moment to review the latest ASCO News
- Legislation Aims to Increase HPV Vaccine Awareness, Access, and Research
- FDA Approves Lorlatinib for Metastatic ALK-positive NSCLC
- Individuals With Cancer Need COVID-19 Vaccination, Cancer Care Providers Can Help With Distribution
- Eligible Clinicians Will Not Face Payment Penalties for MIPS Performance in 2020
- Bipartisan Legislation Creating Step Therapy Safeguards Introduced in Senate
- Executive Order Aims to Secure Access to Essential Pharmaceuticals by Strengthening Supply Chains
- New Online Community Fosters Collaboration Between Members of Oncology State Societies
- FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma
- Oncology Clinician Well-Being Roadmap Provides Five-Year Plan to Address Provider Burnout
- Eleven Oncology Practices Receive Quality Certification from the Association for Clinical Oncology
- FDA Approves Cemiplimab-rwlc for Non-small Cell Lung Cancer with High PD-L1 Expression
- ASCO Supports ACC’s New Cancer Care Course
- Actions Early in Biden Administration Mirror ASCO Road to Recovery Report
- States Must Include Patients with Cancer on COVID-19 Vaccine Priority List
- Support Increased Funding for Cancer Research in Fiscal Year 2022